Acrospire Investment Management LLC - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 38 filers reported holding CYTOSORBENTS CORP in Q1 2017. The put-call ratio across all filers is 2.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q2 2017$13,000
-18.8%
2,943
-15.7%
0.01%
-7.7%
Q1 2017$16,000
-52.9%
3,491
-43.9%
0.01%
-7.1%
Q4 2016$34,000
+277.8%
6,223
+330.1%
0.01%
+133.3%
Q3 2016$9,0001,4470.01%
Other shareholders
CYTOSORBENTS CORP shareholders Q1 2017
NameSharesValueWeighting ↓
Skylands Capital, LLC 815,869$3,141,0000.46%
Sargent Investment Group, LLC 499,010$1,921,0000.36%
Anson Funds Management LP 74,440$287,0000.33%
One68 Global Capital, LLC 39,241$151,0000.33%
Granahan Investment Management 678,618$2,613,0000.12%
Winning Points Advisors, LLC 30,000$115,0000.07%
Avenir Corp 150,600$580,0000.06%
HighMark Wealth Management LLC 10,000$38,0000.04%
Wealthcare Advisory Partners LLC 62,279$240,0000.03%
GSA CAPITAL PARTNERS LLP 64,970$250,0000.03%
View complete list of CYTOSORBENTS CORP shareholders